Senior insider sale
Chief Executive Officer at LEXEO THERAPEUTICS, INC. — senior position signals high conviction
$81.8K
13.52K shares
What this filing means
TOWNSEND RICHARD NOLAN plans to sell 13.52K shares of LEXEO THERAPEUTICS, INC. valued at approximately $81.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/18/2026ACC: 0001959173-26-003723
DirectorOfficer· Chief Executive Officer
Since Feb 2026
13.52K
Shares to sell
$81.8K
Approx. market value
3.34K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
5/15/2026
3.34KTotal acquired3.34K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2026 | Restricted Stock Vesting Compensation | 3.34K | — |
| Total | 3.34K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10.17K
Market value
$64.9K
2/18/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.34K
Market value
$16.9K
5/18/2026
Total
Units
13.52K
Value
$81.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/18/2026 | 10.17K | $64.9K | — | Completed |
| Planned — Approximate Date | ||||
5/18/2026 | 3.34K | $16.9K | NASDAQ | Planned |
| Total | 13.52K | $81.8K | ||